Company received Complete Response Letter from FDA for avasopasem and intends to request Type A meeting with FDA to discuss potential next steps Cash runway extended into Q2 2024 in connection with. -Today at 07:02 am- MarketScreener
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
(Reuters) - Galera Therapeutics Inc said the U.S. health regulator declined to approve its drug to treat radiotherapy-induced severe mouth inflammatio.
Galera Therapeutics, Inc. (GRTX), a clinical-stage biopharmaceutical company focused on cancer treatment, announced Thursday that it has received a Complete Response Letter or CRL from the U.